Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.verified

ANTH

Price:

$0.0001

Market Cap:

$2.62K

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

Industry

Biotechnology

IPO Date

2010-03-01

Stock Exchange

OTC

Ticker

ANTH

The ROE as of December 2025 (TTM) for Anthera Pharmaceuticals, Inc. (ANTH) is -485.59%

According to Anthera Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -485.59%. This represents a change of 84.50% compared to the average of -263.20% of the last 4 quarters.

Anthera Pharmaceuticals, Inc. (ANTH) Historical ROE (quarterly & annually)

How has ANTH ROE performed in the past?

The mean historical ROE of Anthera Pharmaceuticals, Inc. over the last ten years is 605.27%. The current -485.59% ROE has changed -180.23% with respect to the historical average. Over the past ten years (40 quarters), ANTH's ROE was at its highest in in the March 2012 quarter at 1.54%. The ROE was at its lowest in in the September 2017 quarter at -1358.31%.

Quarterly (TTM)
Annual

Average

605.27%

Median

14.40%

Minimum

-499.55%

Maximum

3.93%

Anthera Pharmaceuticals, Inc. (ANTH) ROE by Quarter and Year

Discovering the peaks and valleys of Anthera Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 797.62%

Maximum Annual ROE = 3.93%

Minimum Annual Increase = -697.56%

Minimum Annual ROE = -499.55%

Quarterly (TTM)
Annual
YearROEChange
2017308.19%-171.70%
2016-429.86%388.28%
2015-88.03%-106.57%
20141.34%-697.56%
2013-224.33%-113.32%
20121.68%-437.22%
2011-499.55%607.76%
2010-70.58%-171.02%
200999.39%-97.47%
20083.93%797.62%

Anthera Pharmaceuticals, Inc. (ANTH) Average ROE

How has ANTH ROE performed in the past?

The current ROE of Anthera Pharmaceuticals, Inc. (ANTH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-69.90%

5-year avg

181.30%

10-year avg

605.27%

Anthera Pharmaceuticals, Inc. (ANTH) ROE vs. Peers

How is ANTH’s ROE compared to its peers?

Anthera Pharmaceuticals, Inc.’s ROE is less than PhaseRx, Inc. (101.72%), less than Neurobiological Technologies, Inc. (24.90%), less than Synovics Pharmaceuticals, Inc. (258.22%), less than Cotinga Pharmaceuticals Inc. (132.92%), greater than Sienna Biopharmaceuticals, Inc. (-59.78%), less than Comera Life Sciences Holdings, Inc. (47.45%), less than SheerVision, Inc. (16.68%), greater than GlobeImmune, Inc. (-64.41%), less than OncoVista Innovative Therapies, Inc. (57.94%), less than Viveon Health Acquisition Corp. (-0.50%),

Build a custom stock screener for Anthera Pharmaceuticals, Inc. (ANTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anthera Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anthera Pharmaceuticals, Inc. (ANTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anthera Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Anthera Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Anthera Pharmaceuticals, Inc. (ANTH)?

What is the highest ROE for Anthera Pharmaceuticals, Inc. (ANTH)?

What is the 3-year average ROE for Anthera Pharmaceuticals, Inc. (ANTH)?

What is the 5-year average ROE for Anthera Pharmaceuticals, Inc. (ANTH)?

How does the current ROE for Anthera Pharmaceuticals, Inc. (ANTH) compare to its historical average?